Loading…
Cardiovascular evaluation and endothelial dysfunction in Cushing syndrome following remission: a prospective study
Purpose Cushing syndrome (CS) is a well-known risk factor for cardiovascular morbidities. We aimed to evaluate endothelial and cardiovascular functions, endothelial mediators and pro-inflammatory cytokines in patients with CS before and after remission. Methods Adult patients with newly diagnosed en...
Saved in:
Published in: | Journal of endocrinological investigation 2024-03, Vol.47 (3), p.645-653 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose
Cushing syndrome (CS) is a well-known risk factor for cardiovascular morbidities. We aimed to evaluate endothelial and cardiovascular functions, endothelial mediators and pro-inflammatory cytokines in patients with CS before and after remission.
Methods
Adult patients with newly diagnosed endogenous CS were included. Metabolic [body mass index (BMI), glucose, and lipid values] and cardiovascular evaluation studies [24-h ambulatory blood pressure monitoring, carotid intima-media thickness (CIMT), flow-mediated dilation (FMD), and echocardiography] were performed, and endothelial mediators [asymmetric dimethyl arginine (ADMA) and endothelin-1 (ET-1)] and pro-inflammatory cytokines [interleukin-1β (IL-1β) and tumor necrosis factor-alpha (TNF-α)] were measured. Control group was matched in terms of age, gender, and BMIs.
Results
Twenty-five patients, mean age 40.60 ± 14.04 years, completed the study. Compared to controls (
n
= 20) mean arterial pressure (MAP) and CIMT were higher (
p
|
---|---|
ISSN: | 1720-8386 0391-4097 1720-8386 |
DOI: | 10.1007/s40618-023-02183-4 |